Scientific activity and scientific production
"Cima's scientific activity has generated publications in journals of high scientific impact, patented biomedical inventions and coordination in international projects."
GLORIA GONZÁLEZ ASEGUINOLAZA
DEPUTY DIRECTOR. CIMA UNIVERSIDAD DE NAVARRA
2022-2023 in data
301
scientific publications in total
487
professionals work at Cima
244
scientific publications
in the first quartile
56
Collaboration agreements
13,26
average impact factor
with authorship
+600
national and international
media coverage
with authorship
More information
Outstanding scientific publications
Year 2022
|
|
|
Alonso MM et al. New England Journal of Medicine. |
| Pastor F. Molecular Cancer. División de Innovación Tecnológica Primer decil. Top 3 |
|
|
|
Pastor F. Molecular Cancer. |
|
|
| Berraondo P et al. Annals of Oncology. División de Cáncer Primer decil. |
|
|
| Calvo A et al. Nature Medicine División de Cáncer Primer decil. Top 3 |
|
|
| San Miguel J et al. Journal of Clinical Oncology. División de Cáncer Primer decil |
|
|
| Diez J et al. European Heart Journal. División Cardiovascular Primer decil. Top 3 |
| Paiva B et al. Journal of ClinicalOncology. División de Cáncer Primer decil. |
| Lecanda F et al. Cancer Discovery. Colaboración Dr. Vicent División de Cáncer Primer decil |
|
|
| San Miguel J et al. The Lancet Haematology. División de Cáncer Primer decil. Top 3 |
|
|
| Melero I et al. Cancer Discovery División de Cáncer Primer decil. |
| Odero MD et al. Blood. División de Cáncer Primer decil. Top 3 |
| Prósper F et al. Cell Metabolism. División de Cáncer Primer decil. Top 3 |
| Fontanellas A et al. Science Traslational Medicine. División de Cáncer Primer decil. Top 3 |
|
|
| Dubrot J et al. Nature Immunology División de Cáncer Primer decil. |
|
|
| Ortiz de Solórzano C et al. Medical Image Analysis División de Innovación Tecnológica Primer decil. Top 3 |
Scientific activity of the
Cima Universidad de Navarra
Latest scientific publications
- Recovery of uninvolved heavy/light chain pair immunoparesis in newly diagnosed transplant-eligible myeloma patients complements the prognostic value of minimal residual disease detection Jun 1, 2024 | Magazine: Haematologica
- CD3 aptamers promote expansion and persistence of tumor-reactive T cells for adoptive T cell therapy in cancer Apr 23, 2024 | Magazine: Molecular Therapy Nucleic Acids
- New insights into the regulation of bile acids synthesis during the early stages of liver regeneration: A human and experimental study Apr 19, 2024 | Magazine: Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Nigrostriatal degeneration determines dynamics of glial inflammatory and phagocytic activity Apr 12, 2024 | Magazine: Journal of Neuroinflammation